Antimicrobial Resistance (AMR) will reduce global annual GDP by 3.8% by 2050, the World Health Organisation (WHO) said on Friday and added that it could push 24 million more people into extreme poverty. "New global estimates show that in 2019, nearly 5 million human deaths worldwide were associated with bacterial AMR, of which 1.3 million human deaths were directly attributable to bacterial AMR. In a high-impact scenario, AMR will reduce global annual GDP by 3.8 per cent by 2050. If left unchecked, in the next decade, it could result in a GDP shortfall of USD3.4 trillion annually, pushing 24 million more people into extreme poverty," WHO Regional Director for South-East Asia Dr Poonam Khetrapal Singh said in a statement.
